Nothing new in the forum from what I heard. Except going to be very difficult to get, if not impossible, to the interim AD analysis without another CR. Reckon all is hanging out on the XanaCIDD result IMO! Again they have underestimated the cash requirements especially if the retail participation is not flattering.
